BridgeBio Pharma Inc(BBIO)— 技術面狀態
數據截至2026-10-30 — 每個交易日晚間對全部追蹤範圍重新計算。Closelook研究日記,不構成投資建議。
Trades +6.7% vs the 50-day and +3% vs the 200-day average, 19.8% below the 52-week high and +24.5% off the 52-week low; a death cross printed 11 sessions ago. Computed from daily closes.
移動平均線狀態
- 相對20日均線+10.9%
- 相對50日均線+6.7%
- 相對200日均線+3%
- 52週區間低於52週高點19.8% · 高於52週低點24.5%
- 連續走勢連續1個交易日上漲
- 均線交叉死亡交叉(11個交易日前)
- 50日均線交叉股價向上穿越50日均線(2個交易日前)
- 隨機指標%K 93.1 · %D 89.6(黃金交叉)
FAQ · from the current data · as of 2026-10-30
Quick answers
BBIO目前的Closelook訊號是什麼?
Recovery attempt under the 200-day — Trades +6.7% vs the 50-day and +3% vs the 200-day average, 19.8% below the 52-week high and +24.5% off the 52-week low; a death cross printed 11 sessions ago. Computed from daily closes.(截至2026-10-30;訊號看板每個交易日晚間對全部追蹤範圍重新計算。研究日記讀數,不構成投資建議。)
BBIO目前是否位於50日與200日均線上方?
截至2026-10-30,BridgeBio Pharma Inc位於50日均線上方(+6.7%),200日均線上方(+3%);距20日均線+10.9%。
BBIO距52週高點有多遠?
截至2026-10-30,低於52週高點19.8%,高於52週低點24.5%。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- BION.SW BB Biotech AGindustry
- HALO Halozyme Therapeutics Incindustry
- ONC BeiGene, Ltd.industry
- UCB.BR UCB SAindustry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- KOD Kodiak Sciences Incindustry
- REPL Replimune Group Incindustry
- MRNA Moderna Incindustry
- ARQT Arcutis Biotherapeutics Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ABSI Absci Corpindustry
- EXEL Exelixis Incindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- XNCR Xencor Incindustry
- ALK-B.CO ALK-Abelló A/Sindustry
- ADMA ADMA Biologics Incindustry
- VRDN Viridian Therapeutics Incindustry
- IRON Disc Medicine Inc.industry
- BHVN Biohaven Ltd.industry